Lakefront Biotherapeutics director Paulo Fontoura steps down after taking Sanofi R&D chief role

• Lakefront Biotherapeutics said board member Paulo Fontoura resigned following his appointment as executive vice president, global head of R&D Pharma at Sanofi.
• The company expects to name a successor to fill the board vacancy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lakefront Biotherapeutics NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607131601OMX_____EUPR__NL_GNW1001212586_nl) on July 13, 2026, and is solely responsible for the information contained therein.